Column Group IV-A, LP — SEC insider filings

SEC reporting owner CIK 1796353. 29 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2022-01-26 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eikon Therapeutics, Inc. (EIKN)10% owner24 legs · 2,206,960 sh · $39,150,725—14
NGM BIOPHARMACEUTICALS INC (NGM)10% owner2362 legs · 3,690,481 sh · $27,605,175—14
RAPT Therapeutics, Inc. (RAPT)10% owner48 legs · 1,278,450 sh · $13,686,784—4

Insider filings — Column Group IV-A, LP

FiledFormIssuerReported transactionsSource
2026-09-084Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV GP, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Purchase (P): 89,200 @ $11.56EDGAR
2026-02-094Eikon Therapeutics, Inc. (EIKN)
jointly with Column Group IV GP, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 moreEDGAR
2024-12-234RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative)EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2023-11-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62EDGAR
2023-02-014NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00EDGAR
2023-01-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 9,900 @ $5.00EDGAR
2023-01-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00EDGAR
2023-01-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 5,378 @ $4.95EDGAR
2023-01-124NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76EDGAR
2022-12-144NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 300 @ $4.98EDGAR
2022-11-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00EDGAR
2022-11-074NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72EDGAR
2022-10-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 76,877 @ $4.86EDGAR
2022-10-274NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85EDGAR
2022-06-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50EDGAR
2022-06-064NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03EDGAR
2022-06-024NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45EDGAR
2022-05-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45EDGAR
2022-05-274RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 1,837 @ $12.45 · Purchase (P): 63 @ $12.45EDGAR
2022-05-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43EDGAR
2022-05-254RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 9,898 @ $12.50 · Purchase (P): 338 @ $12.50 · Purchase (P): 15,776 @ $12.00 · Purchase (P): 538 @ $12.00EDGAR
2022-05-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48EDGAR
2022-05-194NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20EDGAR
2022-05-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90EDGAR
2022-05-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 moreEDGAR
2022-05-124RAPT Therapeutics, Inc. (RAPT)
jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 1,208,750 @ $10.67 · Purchase (P): 41,250 @ $10.67EDGAR
2022-05-114NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36EDGAR
2022-01-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796353 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs